GaudetD, et al.Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: An open-label trial. Gene Ther, 2013; 20:361–369.
2.
NarayananG, et al.Clinical development of gene therapy needs a tailored approach: A regulatory perspective from the European Union. Hum Gene Ther Clin Dev, 2014; 25:1–6.
3.
O'SullivanBP, OrensteinDM, MillaCE. Pricing for orphan drugs: Will the market bear what society cannot?. JAMA, 2013; 310:1343–1344.
4.
Protection of human subjects; Belmont Report: notice of report for public comment. Fed Regist, 1979; 44:23191–23197.
